Skip to content

EBITDA at other companies

ITG
Integer HoldingsITGR
$66.88M-15.8%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$74.65M+6.2%
Baxter International logo
Baxter InternationalBAX
Boston Scientific logo
Boston ScientificBSX
Medtronic logo
MedtronicMDT
Abbott logo
AbbottABT

Other financials

Income statement

See full
Revenue$199.4M+25.7%
Gross profit$141.4M+29.4%
Operating income-$16.2M+50.3%
Net income-$13.9M+54.6%
EPS (diluted)-$0.43+55.7%

Balance sheet

See full
Cash & equivalents$248.5M-35.2%
Total debt$79.0M-10.5%
Total equity$161.2M+86.0%
Total assets$1.0B+8.7%

Cash flow

See full
Operating cash flow-$26.2M-232%
CapEx$6.9M-26.7%
Free cash flow-$33.1M-91.1%

Valuation

See full
Market cap$3.62B+16.0%

Profitability

See full
Gross margin71%+1.6pp
Operating margin-5.5%-2.2pp
Net margin-7.3%-3.1pp
FCF margin2.4%

Returns & leverage

See full
Return on equity-53.1%-17.4pp
Debt / equity0.5×-0.5×
Current ratio5.2×-0.5×

Where this comes from

Calculated from iRhythm Holdings, Inc. ’s reported figures.

$16.2Mebit+
$5.0MDepreciation Depletion & Amortization
=-$11.14M

The official record: iRhythm Holdings, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRhythm Holdings, Inc. 's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRhythm Holdings, Inc. 's EBITDA?
iRhythm Holdings, Inc. (IRTC) reported EBITDA of -$11.14M in Q1 2026.
How has iRhythm Holdings, Inc. 's EBITDA changed year-over-year?
iRhythm Holdings, Inc. 's EBITDA increased by 59.3% year-over-year, from -$27.35M to -$11.14M.
What is the long-term trend for iRhythm Holdings, Inc. 's EBITDA?
Over 4 years (2021 to 2025), iRhythm Holdings, Inc. 's EBITDA has grown at a -18.9% compound annual growth rate (CAGR), from -$90.1M to -$38.95M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.